Gene therapy (original) (raw)

Latest News for: Gene therapy

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Nasdaq Globe Newswire 15 Jun 2026

SUNRISE-FA 2 study parameters include LVMI primary endpoint, 6-month topline efficacy analysis, inclusion criteria focused on abnormal baseline LVMI and open-label trial design� ... .

Edit

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia (Lexeo Therapeutics Inc)

Public Technologies 15 Jun 2026

Food and Drug Administration (FDA) for gene therapy candidate LX2006 under the accelerated approval pathway in 2028.

Edit

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia (Form 8-K) (Lexeo Therapeutics Inc)

Public Technologies 15 Jun 2026

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia ... Food and Drug Administration (FDA) for gene therapy candidate LX2006 under the accelerated approval pathway in 2028.

Edit

Sickle Cell Disease: सिकल सेल रोग में कितना प्रभावी है BMT और Gene Therapy? जानिए ...

DNA India 11 Jun 2026

इस बीमारी में BMT और Gene Therapy कितना प्रभावी है, ...

Edit

World’s First Anti-Ageing Gene Therapy Trial in Humans: How ER-100 Aims to Reverse Cellular Ageing and Restore Vision

Gulf News 11 Jun 2026

A human has received a gene therapy designed to partially ...

Edit

Israeli infant receives first gene therapy for rare genetic epilepsy

Cleveland Jewish News 10 Jun 2026

Researchers say the experimental treatment could open new avenues for addressing severe inherited neurological disorders once considered untreatable ... .

Edit

New Gene Therapy Uses Harmless Virus To Target Muscle Spasms, Study Finds

NDTV 10 Jun 2026

The findings showed that animals receiving the treatment experienced a gradual reduction in muscle spasticity. Significant improvements began to appear several weeks after therapy and continued over... .

Edit

Israeli hospital performs world's first experimental gene therapy for rare genetic epilepsy

The Jerusalem Post 09 Jun 2026

The treatment, administered at Schneider Children’s Medical Center of Israel in Petah Tikva, is a major milestone in the development of precision genetic therapies for rare neurological disorders ....

Edit

Israeli hospital performs world’s first experimental gene therapy for rare genetic epilepsy

Virtual Jerusalem 09 Jun 2026

Edit

Gene Therapy Approach Reduces Muscle Spasticity After Chronic Spinal Cord Injury (UCSD - University of California - San Diego)

Public Technologies 09 Jun 2026

Gene therapy Muscle spasticity Spinal cord injury Pre-clinical study Share This. ... In a recent preclinical study, researchers evaluated a gene therapy approach designed to restore the nerve signals that help keep muscle activity under control.

Edit

Lipid Nanoparticles and RNA Therapeutics: Solving the Delivery Challenge at the Heart of Gene Therapy (Ascendia Pharmaceuticals Inc)

Public Technologies 09 Jun 2026

Of all the progress made in RNA and gene-based therapies, one challenge keeps resurfacing ... Gene Therapy and the Shift Toward Non-Viral Delivery. At the same time, there's been a noticeable shift in how gene therapies are being approached.

Edit

First-in-the-World Gene Therapy Delivers Missing Gene Directly to Infant's Brain, Marking Historic Milestone in Precision Medicine

Nasdaq Globe Newswire 08 Jun 2026

Rami Aqeilan ... Rami Aqeilan .

Edit

Public Technologies 08 Jun 2026

[...]. This is an abstract of the document. To keep reading, click here and get access to the original version.

Edit

Experimental gene therapy shows promise in fighting toxic protein in brain, without removing the toxin

The San Diego Union-Tribune 06 Jun 2026

UCSD study says the therapy increased ...

Edit

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Hastings Tribune 05 Jun 2026

... 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc.